Cyclana Bio is addressing a need to better serve millions of women by developing physiologically relevant models and utilising AI-driven multi-scale data integration to enable the discovery of druggable targets to improve treatment outcomes.
Cyclana Bio has raised €5.8M across 1 funding round from 5 investors, most recently a Pre-Seed round in Oct 2025. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-22 | Pre-Seed | €5.8M |
| Angel Investors,Cocoa VC,Eka VC,NfX,Wilbe Capital |
| View deal → |
